103 related articles for article (PubMed ID: 16167020)
1. BSA-based dosing and alternative approaches.
Sparreboom A
Clin Adv Hematol Oncol; 2005 Jun; 3(6):448-50. PubMed ID: 16167020
[No Abstract] [Full Text] [Related]
2. Flat-fixed dosing versus body surface area based dosing of anticancer drugs in adults: does it make a difference?
Mathijssen RH; de Jong FA; Loos WJ; van der Bol JM; Verweij J; Sparreboom A
Oncologist; 2007 Aug; 12(8):913-23. PubMed ID: 17766650
[TBL] [Abstract][Full Text] [Related]
3. A cross-sectional study comparing variation in body surface area and chemotherapy dosing in pediatric oncology using two different methods.
Jastaniah W; Aseeri M
J Oncol Pharm Pract; 2010 Sep; 16(3):189-93. PubMed ID: 19808711
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an alternate dosing strategy for cisplatin in patients with extreme body surface area values.
Loos WJ; de Jongh FE; Sparreboom A; de Wit R; van Boven-van Zomeren DM; Stoter G; Nooter K; Verweij J
J Clin Oncol; 2006 Apr; 24(10):1499-506. PubMed ID: 16574999
[TBL] [Abstract][Full Text] [Related]
5. [Anticancer drug dosing--pharmacogenomic biomarkers or body surface area?].
Lehne G; Bjørheim J; Saeter G
Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1040-4. PubMed ID: 17457389
[TBL] [Abstract][Full Text] [Related]
6. [Individual therapy in oncology].
Jaehde U
Med Monatsschr Pharm; 2003 May; 26(5):155-8. PubMed ID: 12784504
[No Abstract] [Full Text] [Related]
7. Dosing strategies for anticancer drugs: the good, the bad and body-surface area.
Felici A; Verweij J; Sparreboom A
Eur J Cancer; 2002 Sep; 38(13):1677-84. PubMed ID: 12175683
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of fixed dosing of new anticancer agents in phase I studies.
Levêque D
Anticancer Res; 2008; 28(5B):3075-7. PubMed ID: 19031959
[TBL] [Abstract][Full Text] [Related]
9. [Body Surface Area Formulas for the Calculation of the Chemotherapy Dosage].
Hatahira H; Iguchi K; Sasaoka S; Motooka Y; Hasegawa S; Naganuma M; Fukuda A; Ohmori T; Yoshida T; Mogushi K; Nakamura M
Gan To Kagaku Ryoho; 2017 Nov; 44(11):1011-1015. PubMed ID: 29138378
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA)>2 m2.
Schwartz J; Toste B; Dizon DS
Gynecol Oncol; 2009 Jul; 114(1):53-6. PubMed ID: 19359030
[TBL] [Abstract][Full Text] [Related]
11. The scientific basis of body surface area-based dosing.
Chatelut E; Puisset F
Clin Pharmacol Ther; 2014 Apr; 95(4):359-61. PubMed ID: 24646485
[No Abstract] [Full Text] [Related]
12. Flat-fixed dosing versus body surface area based dosing of anticancer drugs: there is a difference.
Hempel G; Boos J
Oncologist; 2007 Aug; 12(8):924-6. PubMed ID: 17766651
[No Abstract] [Full Text] [Related]
13. [Drug dosing in overweight and underweight].
Raknes G; Schjøtt JD
Tidsskr Nor Laegeforen; 2008 Aug; 128(16):1843-4. PubMed ID: 18787597
[No Abstract] [Full Text] [Related]
14. Chemotherapy dosing part I: scientific basis for current practice and use of body surface area.
Kaestner SA; Sewell GJ
Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):23-37. PubMed ID: 17305252
[TBL] [Abstract][Full Text] [Related]
15. Getting the right dose in cancer chemotherapy--time to stop using surface area?
Newell DR
Br J Cancer; 2002 Apr; 86(8):1207-8. PubMed ID: 11953873
[No Abstract] [Full Text] [Related]
16. [Lower costs for anticancer drugs by safety margin around calculated dose and by fine-tuning on ampoule strength].
Mertens S; de Jongh FE
Ned Tijdschr Geneeskd; 2009; 153():B162. PubMed ID: 19785801
[TBL] [Abstract][Full Text] [Related]
17. Can chemotherapy dosing be individualized?
Weiss PA
Clin J Oncol Nurs; 2008 Dec; 12(6):975-7. PubMed ID: 19064391
[No Abstract] [Full Text] [Related]
18. Developing a new framework for dose calculation.
Gurney H
J Clin Oncol; 2006 Apr; 24(10):1489-90. PubMed ID: 16574997
[No Abstract] [Full Text] [Related]
19. Body-surface area as a basis for dosing of anticancer agents: science, myth, or habit?
Ratain MJ
J Clin Oncol; 1998 Jul; 16(7):2297-8. PubMed ID: 9667242
[No Abstract] [Full Text] [Related]
20. Constancy in integrated cisplatin plasma concentrations among pediatric patients.
Goodisman J; Souid AK
J Clin Pharmacol; 2006 Apr; 46(4):443-8. PubMed ID: 16554452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
